Cannabis Report
Home > Boards > US Listed > Biotechs >

Progenics Pharmaceuticals Inc. (PGNX)

PGNX RSS Feed
Add PGNX Price Alert      Hide Sticky   Hide Intro
Moderator: finesand
Search This Board: 
Last Post: 9/20/2018 11:37:58 AM - Followers: 67 - Board type: Free - Posts Today: 0

http://www.progenics.com/

http://finance.yahoo.com/q/ks?s=PGNX

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for the treatment of unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States. It primarily focuses on the areas of gastroenterology, virology, and oncology. The company's development programs and product candidates include methylnaltrexone-subcutaneous, which completed Phase 3 clinical trial for the treatment of opioid-induced constipation; methylnaltrexone-intravenous, which is under Phase 3 clinical trial for the management of post-operative ileus; and Methylnaltrexone-Oral, a Phase 2 clinical trial oral form for the treatment of opioid-induced constipation. It is also developing PRO 140 Phase 1b clinical trial, designed to block HIV infection by inhibiting virus-cell binding; ProVax, a vaccine product candidate for the prevention of HIV infection or therapeutic treatment for HIV-positive individuals; and GMK Vaccine, a therapeutic vaccine, which is in Phase 3 clinical trial for the prevention of recurrence of melanoma. In addition, the company engages in a research program to discover treatments for hepatitis C, a chronic liver disease that block viral entry into cells. Further, Progenics Pharmaceuticals, through a joint venture with Cytogen Corporation, is developing in vivo immuno-therapies for treatment of prostate cancer, including a human monoclonal antibody-drug conjugate directed against prostate-specific membrane antigen (PSMA). The company's PSMA vaccine is in Phase 1 clinical testing. It has a collaboration agreement with Wyeth Pharmaceuticals to develop and commercialize subcutaneous, intravenous, and oral forms of methylnaltrexone. The company was incorporated in 1986 and is based in Tarrytown, New York.





 

Cannabis Report
PGNX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PGNX News: Progenics Announces Addition of AZEDRA® (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochrom... 09/17/2018 06:00:00 AM
PGNX News: Current Report Filing (8-k) 09/12/2018 04:16:00 PM
PGNX News: Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404 09/12/2018 04:01:00 PM
PGNX News: Current Report Filing (8-k) 08/10/2018 04:21:38 PM
PGNX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 08/08/2018 04:14:13 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#741  Sticky Note PGNX Recent Events & Catalysts finesand 09/17/18 11:10:13 PM
#746   It's not clear what the barrier to entry vinmantoo 09/20/18 11:37:57 AM
#745   It's not clear what the barrier to entry oc631 09/19/18 03:24:22 PM
#744   You should also mention that Azedra patents expire vinmantoo 09/19/18 02:15:49 PM
#743   oc631 - thank you, fair restriction finesand 09/18/18 11:15:15 PM
#742   You should also mention that Azedra patents expire oc631 09/18/18 08:55:59 PM
#741   PGNX Recent Events & Catalysts finesand 09/17/18 11:10:13 PM
#740   NCCN Guidelines have been updated with AZEDRA, the finesand 09/17/18 10:55:56 PM
#739   ron- 5/2 RELISTOR® Injection Protected from Generic Competition finesand 09/17/18 10:51:52 PM
#738   vinm- yes, the capital raise was top notch, finesand 09/17/18 10:47:46 PM
#737   PGNX Recent Events & Catalysts finesand 09/17/18 10:43:21 PM
#736   it looks like a really smart move now oc631 09/13/18 03:01:25 PM
#735   it looks like a really smart move now oc631 09/13/18 03:00:55 PM
#734   The first sale of Azedra triggers an $8M vinmantoo 09/13/18 11:37:15 AM
#733   I agree about this stock. Makes no sense. oc631 09/12/18 08:02:25 PM
#732   I agree about this stock. Makes no sense. vinmantoo 09/12/18 07:43:30 PM
#731   I agree about this stock. Makes no sense. TechKim 09/12/18 03:13:14 PM
#730   Sometimes you have to look at the price vinmantoo 09/07/18 10:37:12 PM
#729   Looking like a bounce off of 7.55 to Zilla 08/18/18 12:15:14 PM
#728   WOW Management hates it's stock being over 8.50. Zilla 08/08/18 02:58:42 PM
#727   Nice. MegaDeath 08/03/18 01:14:19 PM
#726   New 52 week high :) vinmantoo 08/03/18 12:26:06 PM
#725   New 52 week high :) MegaDeath 08/03/18 11:13:22 AM
#724   My English sounds about the same. I TechKim 07/31/18 03:48:34 PM
#723   I increased my PGNX holdings by 10% today vinmantoo 07/31/18 01:15:00 PM
#722   Down 7% Are you f ing kidding me??? vinmantoo 07/31/18 10:53:29 AM
#721   Down 7% Are you f ing kidding me??? Sage7243 07/31/18 09:40:34 AM
#720   My apologies. I could hardly believe my eyes. TechKim 07/30/18 04:56:40 PM
#719   Another link about FDA approval of Azedra. vinmantoo 07/30/18 04:07:32 PM
#718   link for FDA approval. Just search for Azedra MegaDeath 07/30/18 03:41:32 PM
#717   Thank you for the fake news. TechKim 07/30/18 03:35:38 PM
#716   Approved according to FDA website. chmcnfunds 07/30/18 03:12:46 PM
#715   Out near the EOD @ $7.60. Was in chmcnfunds 07/27/18 04:04:12 PM
#714   Maybe associated with the reversal today (together with chmcnfunds 07/26/18 11:02:12 AM
#713   Good to know!!! Thanks!!! rocket1010 07/25/18 07:29:45 PM
#712   Highest short interest in 1 year: chmcnfunds 07/25/18 12:09:19 PM
#711   Close to 2nd support level: chmcnfunds 07/24/18 02:43:45 PM
#710   In @ $7.75. Thought it was a gift chmcnfunds 07/24/18 01:54:58 PM
#709   It won't be long until the FDA decision vinmantoo 07/17/18 01:00:38 AM
#708   Hashing through phase 2 1404 info this weekend. rocket1010 07/16/18 06:10:44 PM
#707   $PGNX could spike hard any day now. Sage7243 06/13/18 06:08:20 AM
#706   I like this ticker! Sage7243 05/10/18 12:15:53 PM
#705   Summary Judgment Granted Upholding the Validity of Formulation vinmantoo 05/03/18 01:06:19 AM
#704   Summary Judgment Granted Upholding the Validity of Formulation ronpopeil 05/02/18 08:29:17 PM
#703   Bought my first taste back since selling last ER Zilla 04/30/18 08:08:33 PM
#702   Yeah it’s really crazy how similar the stories ronpopeil 03/23/18 02:13:40 PM
#701   Ron, that scenario for PGNX would suit me fine. vinmantoo 03/23/18 01:46:58 PM
#700   Progenics Pharmaceuticals (PGNX unch) plunged over 19% in vinmantoo 03/23/18 01:45:59 PM
#699   PGNX maintained with a strong buy rating at ronpopeil 03/23/18 09:49:33 AM
#698   it's frustrating but this actually reminds me so ronpopeil 03/23/18 09:48:21 AM
#697   Pretty high penalty in the stock price just conix 03/23/18 09:42:51 AM
PostSubject